PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial pits new pancreatic cancer pill against standard chemo
Disease control OngoingThis study is testing whether a new oral drug called daraxonrasib works better than standard chemotherapy for people with advanced pancreatic cancer that has spread. The trial involves 501 patients whose cancer has continued to grow despite previous treatment. Researchers will co…
Matched conditions: PDAC
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can enzyme pills help cancer patients keep weight on?
Symptom relief OngoingThis study is testing whether pancreatic enzyme replacement therapy (PERT) can help people with advanced pancreatic cancer maintain their body weight while on chemotherapy. Researchers are comparing two different dosing schedules of the enzyme supplement pancrelipase. The main go…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC